Figshareopen access
Chromone-based PDE2 inhibitors as potential prostate cancer therapeutics
pharmacology and pharmaceutical sciences not elsewhere classified, prostate;cancer, phosphodiesterases;inhibitors, phosphodiesterases;inhibitors therapeutic use, phosphodiesterase inhibitors;pharmacology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 363814
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.